Home ›
Trademark Categories ›
Chemicals ›
2016 ›
RI ›
RIGENASE
Trademark search for:
RIGENASE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-04-14 — Application filed
2016-09-22 — Sn assigned for sect 66a appl from ib
2016-09-24 — Application filed
2016-09-24 — Assigned to examiner
2016-09-28 — Application filed
2016-09-28 — Final disposition recorded
2016-09-29 — Office action issued
2016-09-30 — Office action issued
2016-09-30 — Office action issued
2016-10-21 — Office action issued
2016-12-23 — Office action issued
2017-01-19 — Assigned to lie
2017-01-23 — Teas/email correspondence entered
2017-01-23 — Correspondence received in law office
2017-02-04 — Approved for pub - principal register
2017-02-14 — Law office publication review completed
2017-03-01 — Notification of notice of publication e-mailed
2017-03-01 — Notice of start of opposition period created, to be sent to ib
2017-03-01 — Notification of possible opposition sent to ib
2017-03-17 — Notification processed by ib
2017-03-21 — Published for opposition
2017-03-21 — Official gazette publication confirmation e-mailed
2017-04-05 — Extension of time to oppose received
2017-05-22 — Teas post publication amendment received
2017-05-25 — Assigned to petition staff
2017-05-30 — Changes/corrections after pub approval entered
2017-07-30 — Extension of time to oppose process - terminated
2017-07-31 — Assigned to examiner
2017-09-05 — Registered-principal register
2017-12-05 — Final disposition recorded
2017-12-15 — Final disposition recorded
2017-12-16 — Final disposition recorded
2018-01-26 — Final disposition recorded
2020-04-02 — New representative at ib received
2022-09-05 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-03-22 — Cancelled section 71
2024-03-22 — Final status recorded
2024-11-23 — Total invalidation of reg ext protection created
2024-12-12 — Total invalidation of reg ext protection sent to ib
2024-12-12 — Invalidation processed
2025-01-04 — Total invalidation processed by the ib
Owner Information
FARMACEUTICI DAMOR S.P.A.
IT
FARMACEUTICI DAMOR S.P.A.
IT
FARMACEUTICI DAMOR S.P.A.
IT
Correspondent
Lawrence E. Abelman Abelman Frayne & Schwab 666 3RD AVE 10th Floor New York, NY 10017
Filing Details
Filing Date:
2016-04-14
Status Date:
2024-03-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.